SBS patients with enteral autonomy
| Total | Antenatal causes | Postnatal causes | |||||
|---|---|---|---|---|---|---|---|
| (n=40) | Total N=22 | Group A (n=14) | Group B (n=8) | Total N=18 | Group A (n=14) | Group B (n=4) | |
| Bowel Lengthening |
8/40
(20% ) |
6/21
(28.6% ) |
3/14
(21.4% ) |
3/8
(37.5% ) |
1/18
(51.7.5% ) |
1/14
(7.1% ) | 0 |
| ICV present |
17/38
(44.7% ) |
9/22
(40.9% ) |
6/13
(46.2% ) |
3/8
(37.5% ) |
8/17
(47% ) |
7/13
(53.8% ) |
1/4
(25% ) |
| Ostomy |
2/40
(5% ) |
1/22
(4.5% ) |
1/14
(7.1% ) | 0 |
1/18
(5.5% ) | 0 |
1/4
(25% ) |
| Mean time on PN (d) |
473.7
±163.4 |
655.9
±268 |
558.9
±307.3 |
825.6
±600 |
250.9
±115.2 |
185.2
±63.6 |
480.7
±637.6 |
| SIBO | 19/40 (47.5%) |
13/22
(59.1% ) |
10/14
(71.4% ) |
3/8
(37.5% ) |
6/18
(33.3% ) |
5/14
(35.7% ) |
1/4
(25% ) |
| Nocturnal Stooling |
3/42
(7% ) |
3/20
(15% ) |
3/12
(25% ) | 0 | 0 | 0 | 0 |
| Micro-nut/ents supp/tion | |||||||
| Vit B12 |
13/38
(34.2% ) |
12/21
(57.1% ) |
8/13
(61.5% ) |
4/8
(50% ) |
1/17
(5.9% ) |
1/14
(7.1% ) | 0 |
| Iron |
19/39
(48.7% ) |
11/21
(52.4% ) |
6/13
(46.2% ) |
5/8
(62.5% ) |
8/18
(44.4% ) |
6/14
(42.9% ) |
2/4
(50% ) |
| Vit A |
7/33
(21.2% ) |
4/16
(25% ) | 0 |
4/8
(50% ) |
3/17
(17.6% ) |
2/13
(15.4% ) |
1/4
(25% ) |
| Vit D |
25/39
(64.1% ) |
17/22
(77.3% ) |
12/14
(85.7% ) |
5/8
(62.5% ) |
8/17
(47.1% ) |
7/14
(50% ) |
1/3
(33.3% ) |
| Vit E |
10/35
(28.6% ) |
7/18
(28.9% ) |
4/10
(40% ) |
3/8
(37.5% ) |
3/17
(17.6% ) |
2/13
(15.4% ) |
1/4
(25% ) |